Dr. Henry Ji, Sorrento Therapeutics’ Chairman and CEO and Scilex Holding Company’s Executive Chairman, to Present at the B. Riley Securities’ 2022 Virtual Neuro & Opthalmology Healthcare Con Apr 25, 2022 09:00AM
Sorrento's (SRNE) Scilex Holding Company Enters Non-Binding Term Sheet for $5B Committed Equity Financing Facility, Effective Upon Close of Merger with Vickers Vantage Mar 25, 2022 09:03AM
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., enters into a Non-Binding Term Sheet for a $5 Billion Committed Equity Financing Facility to be Effective in Connect Mar 25, 2022 09:00AM